Additional References:
Alzheimer's Association. 2017 Alzheimer's disease facts and figures. Alzheimer's & Dementia. 2017;13:325-373.
Bird TD. Alzheimer disease overview. In: Pagon RA, Adam MP, Ardinger HH, et al, eds.
GeneReviews. Seattle, Wash: University of Washington; 2014.
PubMed 20301340 Accessed 2/6/2023.
Du, Y; Dodel, R; Hampel, H; Buerger, K; Lin, S; Eastwood, B; Bales, K; Gao, F; et al. (2001). "Reduced levels of amyloid beta-peptide antibody in Alzheimer disease". Neurology. 57 (5): 801–5. doi:10.1212/wnl.57.5.801. PMID11552007. Accessed 2/6/2023. Herukka SK, Simonsen AH, Andreasen N, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimers Dement. 2017;13:285-295.
Hansson, O; Zetterberg, H; Vanmechelen, E; Vanderstichele, H; Andreasson, U; Londos, E; Wallin, A; Minthon, L; Blennow, K (2010). "Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment". Neurobiology of Aging. 31 (3): 357–67. doi:10.1016/j.neurobiolaging.2008.03.027. PMID18486992. Accessed 2/6/2023. Janelidze S, Zetterberg H, Mattsson N, et al. CSF Abeta42/Abeta40 and Abeta42/Abeta38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154-165.
Lewczuk P, Matzen A, Blennow K, et al. Cerebrospinal fluid Abeta42/40 corresponds better than Abeta42 to amyloid PET in Alzheimer's disease. J Alzheimers Dis. 2017;55:813-822.
Maiti TK, Konar S, Bir S, et al. Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review. Neurosurg Focus. 2015;39:E3. doi:10.3171/2015.8.FOCUS15329
Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252-265.
Simonsen AH, Herukka SK, Andreasen N, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimers Dement. 2017;13:274-284